| Pharmacokinetics of Hydroxychloroquine and Its Clinical Implications in Chemoprophylaxis against Malaria Caused by Plasmodium vivax HS Lim, JS Im, JY Cho, KS Bae, TA Klein, JS Yeom, TS Kim, JS Choi, ... Antimicrobial agents and chemotherapy 53 (4), 1468-1475, 2009 | 211 | 2009 |
| Effect of omeprazole on the pharmacokinetics of moclobemide according to the genetic polymorphism of CYP2C19 KS Yu, DS Yim, JY Cho, SS Park, JY Park, KH Lee, IJ Jang, SY Yi, KS Bae, ... Clinical Pharmacology & Therapeutics 69 (4), 266-273, 2001 | 107 | 2001 |
| Pharmacokinetics and pharmacodynamics of propofol microemulsion and lipid emulsion after an intravenous bolus and variable rate infusion KM Kim, BM Choi, SW Park, SH Lee, LV Christensen, J Zhou, BH Yoo, ... The Journal of the American Society of Anesthesiologists 106 (5), 924-934, 2007 | 104 | 2007 |
| The thickness and texture of temporal bone in brain CT predict acoustic window failure of transcranial Doppler JH Kwon, JS Kim, DW Kang, KS Bae, SU Kwon Journal of Neuroimaging 16 (4), 347-352, 2006 | 96 | 2006 |
| Pharmacokinetic and pharmacodynamic evaluation of a novel proton pump inhibitor, YH1885, in healthy volunteers KS Yu, KS Bae, JH Shon, JY Cho, SY Yi, JY Chung, HS Lim, IJ Jang, ... The Journal of Clinical Pharmacology 44 (1), 73-82, 2004 | 85 | 2004 |
| Tolerability and pharmacokinetics of avanafil, a phosphodiesterase type 5 inhibitor: a single-and multiple-dose, double-blind, randomized, placebo-controlled, dose-escalation … J Jung, S Choi, SH Cho, JL Ghim, A Hwang, U Kim, BS Kim, A Koguchi, ... Clinical therapeutics 32 (6), 1178-1187, 2010 | 81 | 2010 |
| Randomized comparison of four-times-daily versus once-daily intravenous busulfan in conditioning therapy for hematopoietic cell transplantation SG Ryu, JH Lee, SJ Choi, JH Lee, YS Lee, M Seol, EH Hur, SH Lee, ... Biology of Blood and Marrow Transplantation 13 (9), 1095-1105, 2007 | 76 | 2007 |
| Influence of GST gene polymorphisms on the clearance of intravenous busulfan in adult patients undergoing hematopoietic cell transplantation SD Kim, JH Lee, EH Hur, JH Lee, DY Kim, SN Lim, Y Choi, HS Lim, ... Biology of Blood and Marrow Transplantation 17 (8), 1222-1230, 2011 | 73 | 2011 |
| Effect of the CYP2D6 genotype on the pharmacokinetics of tropisetron in healthy Korean subjects MK Kim, JY Cho, HS Lim, KS Hong, JY Chung, KS Bae, DS Oh, SG Shin, ... European journal of clinical pharmacology 59, 111-116, 2003 | 64 | 2003 |
| Randomised clinical trial: safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple oral doses of tegoprazan (CJ‐12420), a novel potassium … S Han, HY Choi, YH Kim, JY Nam, B Kim, GS Song, HS Lim, KS Bae Alimentary pharmacology & therapeutics 50 (7), 751-759, 2019 | 59 | 2019 |
| Ethnic differences and relationships in the oral pharmacokinetics of nifedipine and erythromycin KS Yu, JY Cho, JH Shon, KS Bae, SY Yi, HS Lim, IJ Jang, SG Shin Clinical Pharmacology & Therapeutics 70 (3), 228-236, 2001 | 50 | 2001 |
| Population pharmacokinetic and pharmacodynamic analysis of tremelimumab in patients with metastatic melanoma E Wang, D Kang, KS Bae, MA Marshall, D Pavlov, K Parivar The Journal of Clinical Pharmacology 54 (10), 1108-1116, 2014 | 47 | 2014 |
| Impact of CYP2D6, CYP3A5, CYP2C19, CYP2A6, SLCO1B1, ABCB1, and ABCG2 gene polymorphisms on the pharmacokinetics of simvastatin and simvastatin acid HY Choi, KS Bae, SH Cho, JL Ghim, S Choe, JA Jung, SJ Jin, HS Kim, ... Pharmacogenetics and genomics 25 (12), 595-608, 2015 | 44 | 2015 |
| Relationship between nurse staffing level and adult nursing-sensitive outcomes in tertiary hospitals of Korea: Retrospective observational study CG Kim, KS Bae International Journal of Nursing Studies 80, 155-164, 2018 | 41 | 2018 |
| A UGT1A1*28 and *6 genotype-directed phase I dose-escalation trial of irinotecan with fixed-dose capecitabine in Korean patients with metastatic colorectal cancer K Kim, HS Kim, SJ Sym, KS Bae, YS Hong, HM Chang, JL Lee, YK Kang, ... Cancer chemotherapy and pharmacology 71, 1609-1617, 2013 | 38 | 2013 |
| Phase II study of S-1 combined with oxaliplatin as therapy for patients with metastatic biliary tract cancer: influence of the CYP2A6 polymorphism on … KP Kim, G Jang, YS Hong, HS Lim, KS Bae, HS Kim, SS Lee, JG Shin, ... British journal of cancer 104 (4), 605-612, 2011 | 37 | 2011 |
| Effects of ketoconazole and rifampicin on the pharmacokinetics of gemigliptin, a dipeptidyl peptidase-IV inhibitor: a crossover drug–drug interaction study in healthy male … YH Noh, HS Lim, SJ Jin, MJ Kim, YH Kim, HR Sung, HY Choi, KS Bae Clinical therapeutics 34 (5), 1182-1194, 2012 | 36 | 2012 |
| Phase I/II and pharmacokinetic study of S-1 and oxaliplatin in previously untreated advanced gastric cancer I Park, JL Lee, MH Ryu, HM Chang, TW Kim, SJ Sym, SS Lee, G Jang, ... Cancer chemotherapy and pharmacology 65, 473-480, 2010 | 35 | 2010 |
| A Phase I Study of UGT1A1 *28/*6 Genotype-Directed Dosing of Irinotecan (CPT-11) in Korean Patients with Metastatic Colorectal Cancer Receiving FOLFIRI KP Kim, YS Hong, JL Lee, KS Bae, HS Kim, JG Shin, JS Lee, TW Kim Oncology 88 (3), 164-172, 2015 | 33 | 2015 |
| A phase I and pharmacologic study of belotecan in combination with cisplatin in patients with previously untreated extensive-stage disease small cell lung cancer DH Lee, SW Kim, KS Bae, JS Hong, C Suh, YK Kang, JS Lee Clinical cancer research 13 (20), 6182-6186, 2007 | 33 | 2007 |
Dong-Seok YimDept Pharmacology Catholic UnivVerified email at catholic.ac.kr
